Lepra irfan
-
Upload
kartikesh-gupta -
Category
Health & Medicine
-
view
220 -
download
0
Transcript of Lepra irfan
![Page 1: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/1.jpg)
DR. MOHD IRFAN
(INTERN)
NATIONAL LEPROSY ERADICATION PROGROM (NLEP)
![Page 2: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/2.jpg)
WHAT IS LEPROSY? It is a chronic infectious
disease caused by M.leprae, an acid fast, rod shaped bacillus. It mainly affects the skin, peripheral nerves, and mucosa of the respiratory tract etc., It has left behind a terrifying image in history and human memory of mutilation, rejection and exclusion from society.
![Page 3: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/3.jpg)
• SPECIFIC LEARNING OBJECTIVES
Burden of leprosy in India Enlist 4 important Milestones in Leprosy Enumerate 5 components of National
Leprosy Eradication Program. Enlist initiatives under Disability
Prevention and Medical Rehabilitation.
![Page 4: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/4.jpg)
burden of leprosy The global registered prevalence of leprosy at the
beginning of 2006 was 219,826 cases. There are now only six countries that have still to reach the elimination target of 1 case per 10,000 population, at the national level.
Based on the reports received from all the states and UTs in India for the year of 2008-09 current leprosy situation in the country has been observed as below. A total of 1.34 lakh new cases were detected during
the year 2008-09, which gives Annual New Case Detection Rate (ANCDR) of 11.19 per 100,000 population. This shows ANCDR reduction of 4.36% from 11.70 during 2007-08.
A total of 0.86 lakh cases are on record as on 1st April 2009 giving a Prevalence rate (PR) of 0.72 leprosy cases per 10,000 population.
Detailed information on new leprosy cases detected during 2008-09 indicates the proportion of MB (48.4), Female (35.2), Child (10.1), Visible Deformity (2.8),
![Page 5: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/5.jpg)
• THE LEPROSY SCENARIO IN THE COUNTRY
![Page 6: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/6.jpg)
• MONTHLY PROGRESS REPORT FOR THE YEAR 2013-14
![Page 7: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/7.jpg)
![Page 8: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/8.jpg)
MILESTONES OF LEPROSY ERADICATION
1948 – Hind Kusht Nivaran Sangh 1955 – National leprosy Control Program 1980 – Dapsone 1982 – MDT 1983 – National Leprosy Eradication Program( MDT
started) 1991 – World Health Assembly resolution to eradicate
leprosy by 2000AD. 1998-2004 – Modified Leprosy Elimination Program . 2005 Dec – Prevalence rate 0.95 /10,000 and
government declared achievement of elimination target. 2005 – NRHM covers NLEP . 2012 - Special action plan for 209 high endemic
districts 16 States/UTs
![Page 9: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/9.jpg)
COMPONENTS OF THE PROGRAM1.Decentralizing2.Capacity building3.Intensified IEC4.Prevention of DPMR5.Intensified monitoring
![Page 10: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/10.jpg)
NATIONAL LEPROSY ERADICATION PROGRAM
OBJECTIVES OF NLEP To achieve elimination of leprosy at national
level by the end of the project
To accomplish integration of leprosy services with general health services in the 27 low endemic states
To proceed with integration of services as rapidly as possible in the 8 high endemic states
![Page 11: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/11.jpg)
• Leprosy - one of the few diseases which can be eliminated
Leprosy meets the demanding criteria for elimination
practical and simple diagnostic tools: can be diagnosed on clinical signs alone;
the availability of an effective intervention to interrupt its transmission: multidrug therapy
a single significant reservoir of infection:
humans.
![Page 12: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/12.jpg)
•STRATEGIES IN NLEP 1. Early detection 2. Regular treatment 3.Public awareness campaigns 4.Medical rehabilitation
![Page 13: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/13.jpg)
Treatment
Rifampicin is given once a month. No toxic effects have been reported in the case of monthly administration. The urine may be coloured slightly reddish for a few hours after its intake, this should be explained to the patient while starting MDT.
Clofazimine is most active when administered daily. The drug is well tolerated and virtually non-toxic in the dosage used for MDT. The drug causes brownish black discoloration and dryness of skin. However, this disappears within few months after stopping treatment. This should be explained to patients starting MDT regimen for MB leprosy.
Dapsone :This drug is very safe in the dosage used in MDT and side effects are rare. The main side effect is allergic reaction, causing itchy skin rashes and exfoliative dermatitis. Patients known to be allergic to any of the sulpha drugs should not be given dapsone
![Page 14: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/14.jpg)
TREATMENT CONTD..
![Page 15: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/15.jpg)
DPMR ACTIVITIES- 3 TIER SYSTEM DPMR ACTIVITIES- 3 TIER SYSTEM
1.Primary level (First level ) 2.Secondary level (Second Level ) 3.Tertiary level ( Third Level ) Central government Institutes ICMR Institute JALMA , Agra .
![Page 16: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/16.jpg)
• ACHIEVEMENTS OF THE PROGRAM01 case per 10,000 population3 States are yet to achieve elimination.More focus is given to the districts and blocksUrban Leprosy Awareness Campaigns AID PROVIDED ARE
Dressing material , ulcer kits.Footwear.83 Reconstructive surgery centres (41+42).Incentives to BPL families.Support from the government.
![Page 17: Lepra irfan](https://reader035.fdocument.pub/reader035/viewer/2022081604/589dbe901a28abf7288b5fe3/html5/thumbnails/17.jpg)
• THE "FINAL PUSH" STRATEGY FOR
THE "FINAL PUSH" STRATEGY FOR LEPROSY ELIMINATION Expand services Ensure new cases Encourage for treatment Promote awareness Set targets Stratify the problem Identify and target Promote campaigns Monitoring by WHO
THANKU